永泰生物-B完成发行新可换股债券及票据

Group 1 - The company Yongtai Bio-B (06978) announced that all conditions precedent under the subscription agreement have been met or waived, if applicable [1] - The company has issued new convertible bonds with a total principal amount of RMB 270 million and notes with a principal amount of RMB 30 million to investors according to the terms and conditions [1] - The proceeds from the subscription will be used exclusively for the full and final repayment of the principal amount of the 2023 convertible bonds, which are due on February 20, 2026 [1]